2017年5月
Recurrent ovarian undifferentiated carcinoma resembling hepatoid morphology treated with pegylated liposomal doxorubicin and bevacizumab
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- ,
- ,
- ,
- ,
- 巻
- 43
- 号
- 5
- 開始ページ
- 957
- 終了ページ
- 961
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1111/jog.13298
- 出版者・発行元
- WILEY
Hepatoid carcinomas are undifferentiated epithelial carcinomas that are pathologically similar to hepatocellular carcinoma, but occur in a variety of organs. Hepatoid carcinomas, as strictly defined, typically produce a-fetoprotein. In addition, a standard effective chemotherapy regimen for hepatoid carcinoma has yet to be established. We present a case of advanced primary ovarian cancer that was pathologically similar to hepatoid carcinoma without staining for a-fetoprotein or hepatocyte paraffin 1. The primary ovarian, metastatic, and recurrent tumors shared similar pathological characteristics. Fourth-line chemotherapy with pegylated liposomal doxorubicin and bevacizumab was effective in treating the recurrent tumor, even though this disease had recurred three times.
- リンク情報
- ID情報
-
- DOI : 10.1111/jog.13298
- ISSN : 1341-8076
- eISSN : 1447-0756
- PubMed ID : 28422375
- Web of Science ID : WOS:000403217900027